{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:26:20Z","timestamp":1783045580700,"version":"3.54.6"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Many treatment options have guaranteed long-term survival in patients with localized prostate cancer and health-related quality of life has become a greater concern for those patients. The purpose of this study was to reveal the health-related quality of life after proton beam therapy and to clarify the differences from other treatment modalities for prostate cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Between January 2011 and April 2016, 583 patients were enrolled in the study and health-related quality of life outcomes using the Expanded Prostate Cancer Index Composite questionnaire were evaluated and compared with previous research targeted at Japanese patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We found a significant decrease in the least square mean scores for urinary and bowel domains excluding the incontinence subscale after proton beam therapy (P\u00a0&amp;lt;\u00a00.0001) and recovery at a year following treatment. The scores for sexual function in patients without androgen deprivation therapy decreased each year after proton beam therapy (P\u00a0&amp;lt;\u00a00.0001). The scores for hormones in patients without androgen deprivation therapy remained high and those of patients with androgen deprivation therapy were lower before treatment but were comparable to those of non-androgen deprivation therapy patients at 2 years post-treatment. We found that the impact of radiotherapy including proton beam therapy on urinary condition and sexual function was lower than that of surgery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>For the first time in Japan, we investigated health-related quality of life using Expanded Prostate Cancer Index Composite questionnaires in patients with prostate cancer after proton beam therapy and compared it with other treatment modalities.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jjco\/hyaa027","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T12:10:19Z","timestamp":1580904619000},"page":"519-527","source":"Crossref","is-referenced-by-count":4,"title":["Health-related quality of life in Japanese patients with prostate cancer following proton beam therapy: an institutional cohort study"],"prefix":"10.1093","volume":"50","author":[{"given":"Kyoko","family":"Matsukawa","sequence":"first","affiliation":[{"name":"Department of Global Health, Medicine and Welfare, Nagasaki University Graduate School of Biomedical Sciences, Atomic Bomb Disease Institute, Nagasaki, Japan"},{"name":"Medipolis Proton Therapy and Research Center, Ibusuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Arimura","sequence":"first","affiliation":[{"name":"Medipolis Proton Therapy and Research Center, Ibusuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Orita","sequence":"first","affiliation":[{"name":"Department of Global Health, Medicine and Welfare, Nagasaki University Graduate School of Biomedical Sciences, Atomic Bomb Disease Institute, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisayoshi","family":"Kondo","sequence":"first","affiliation":[{"name":"Department of Global Health, Medicine and Welfare, Nagasaki University Graduate School of Biomedical Sciences, Atomic Bomb Disease Institute, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Chuman","sequence":"first","affiliation":[{"name":"Medipolis Proton Therapy and Research Center, Ibusuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ogino","sequence":"first","affiliation":[{"name":"Medipolis Proton Therapy and Research Center, Ibusuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Taira","sequence":"first","affiliation":[{"name":"Department of Global Health, Medicine and Welfare, Nagasaki University Graduate School of Biomedical Sciences, Atomic Bomb Disease Institute, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kudo","sequence":"first","affiliation":[{"name":"Department of Radioisotope Medicine, Nagasaki University Graduate School of Biomedical Sciences, Atomic Bomb Disease Institute, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Takamura","sequence":"first","affiliation":[{"name":"Department of Global Health, Medicine and Welfare, Nagasaki University Graduate School of Biomedical Sciences, Atomic Bomb Disease Institute, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"2020050701580181000_ref1","volume-title":"JACR Monograph Supplement No. 2","author":"Katanoda","year":"2019"},{"key":"2020050701580181000_ref2","volume-title":"NCCN Clinical Guidelines in Oncology for Prostate Cancer","author":"National Comprehensive Cancer Network"},{"key":"2020050701580181000_ref3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"2020050701580181000_ref4","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"key":"2020050701580181000_ref5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"key":"2020050701580181000_ref6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.eururo.2017.06.035","article-title":"Quality of life outcomes after primary treatment for clinically localized prostate cancer: a systematic review","volume":"72","author":"Lardas","year":"2017","journal-title":"Eur Urol"},{"key":"2020050701580181000_ref7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/14786440509463378","article-title":"On the \u03b1 particles of radium, and their loss of range in passing through various atoms and molecules","volume":"10","author":"Bragg","year":"1905","journal-title":"Phil Mag"},{"key":"2020050701580181000_ref8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1148\/47.5.487","article-title":"Radiological use of fast protons","volume":"47","author":"Wilson","year":"1946","journal-title":"Radiology"},{"key":"2020050701580181000_ref9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ijrobp.2007.07.2335","article-title":"Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer","volume":"70","author":"Vargas","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020050701580181000_ref10","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1002\/cncr.27398","article-title":"Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger","volume":"118","author":"Hoppe","year":"2012","journal-title":"Cancer"},{"key":"2020050701580181000_ref11","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/cncr.27956","article-title":"Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer","volume":"119","author":"Gray","year":"2013","journal-title":"Cancer"},{"key":"2020050701580181000_ref12","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ijrobp.2013.08.032","article-title":"Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer","volume":"87","author":"Pugh","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020050701580181000_ref13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/cncr.28536","article-title":"Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer","volume":"120","author":"Hoppe","year":"2014","journal-title":"Cancer"},{"key":"2020050701580181000_ref14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijrobp.2016.02.038","article-title":"Five-year biochemical results, toxicity, and patient-reported quality of life after delivery of dose-escalated image guided proton therapy for prostate cancer","volume":"95","author":"Bryant","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020050701580181000_ref15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.rpor.2016.01.002","article-title":"Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: analysis of quality of life and toxicity, PCG GU 002","volume":"21","author":"Vargas","year":"2016","journal-title":"Rep Pract Oncol Radiother"},{"key":"2020050701580181000_ref16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijrobp.2016.02.025","article-title":"Acute toxicity and quality of life in patients with prostate cancer treated with protons or carbon ions in a prospective randomized phase II study-the IPI trial","volume":"95","author":"Habl","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020050701580181000_ref17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.clgc.2017.03.005","article-title":"Patient-reported quality of life after proton beam therapy for prostate cancer: the effect of prostate size","volume":"15","author":"Goenka","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"2020050701580181000_ref18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/0284186X.2018.1427886","article-title":"Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual health","volume":"57","author":"Ho","year":"2018","journal-title":"Acta Oncol"},{"key":"2020050701580181000_ref19","first-page":"657","article-title":"The Japanese translation and cultural adaptation of expanded prostate cancer index composite (EPIC)","volume":"96","author":"Takegami","year":"2005","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"2020050701580181000_ref20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"key":"2020050701580181000_ref21","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.3390\/cancers10040116","article-title":"Proton beam therapy alone for intermediate- or high-risk prostate cancer: an institutional prospective cohort study","volume":"10","author":"Arimura","year":"2018","journal-title":"Cancer"},{"key":"2020050701580181000_ref22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cncr.23139","article-title":"The phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer","volume":"112","author":"Abramowitz","year":"2008","journal-title":"Cancer"},{"key":"2020050701580181000_ref23","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/cam4.1159","article-title":"Long-term outcomes in patients treated with proton therapy for localized prostate cancer","volume":"6","author":"Takagi","year":"2017","journal-title":"Cancer Med"},{"key":"2020050701580181000_ref24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/cam4.1350","article-title":"Long-term outcomes of proton therapy for prostate cancer in Japan: a multi-institutional survey of the Japanese radiation oncology study group","volume":"7","author":"Iwata","year":"2018","journal-title":"Cancer Med"},{"key":"2020050701580181000_ref25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"key":"2020050701580181000_ref26","doi-asserted-by":"crossref","first-page":"e185293","DOI":"10.1001\/jamanetworkopen.2018.5293","article-title":"Prevalence of and factors associated with patient nondisclosure of medically relevant information to clinicians","volume":"1","author":"Levy","year":"2018","journal-title":"JAMA Netw Open"},{"key":"2020050701580181000_ref27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/jjco\/hyp053","article-title":"Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy","volume":"39","author":"Hasine","year":"2009","journal-title":"Jpn J Clin Oncol"},{"key":"2020050701580181000_ref28","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s11136-013-0603-6","article-title":"Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer","volume":"23","author":"Yamamoto","year":"2014","journal-title":"Qual Life Res"},{"key":"2020050701580181000_ref29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/jjco\/hyu052","article-title":"Health-related quality of life in the first year after laparoscopic radical prostatectomy compared with open radical prostatectomy","volume":"44","author":"Hashine","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"2020050701580181000_ref30","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s10147-013-0659-x","article-title":"Assessment of postoperative quality of life: comparative study between laparoscopic and minimum incision endoscopic radical prostatectomies","volume":"19","author":"Muramaki","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"2020050701580181000_ref31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jjco\/hyu173","article-title":"Correlation between the changes in the EPIC QOL scores and the dose-volume histogram parameters in high-dose-rate brachytherapy combined with hypofractionated external beam radiation therapy for prostate cancer","volume":"45","author":"Hashimoto","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"2020050701580181000_ref32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11701-016-0565-0","article-title":"Prospective assessment of time-dependent changes in quality of life of Japanese patients with prostate cancer following robot-assisted radical prostatectomy","volume":"10","author":"Miyake","year":"2016","journal-title":"J Robotic Surg"},{"key":"2020050701580181000_ref33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/iju.13358","article-title":"Assessment of sexual function in Japanese men with prostate cancer undergoing permanent brachytherapy without androgen deprivation therapy: analysis from the Japanese prostate cancer outcome study of permanent Iodine-125 seed implantation database","volume":"24","author":"Okihara","year":"2017","journal-title":"Int J Urol"},{"key":"2020050701580181000_ref34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11701-016-0659-8","article-title":"Health-related quality of life after robot-assisted radical prostatectomy compared with laparoscopic radical prostatectomy","volume":"11","author":"Koike","year":"2017","journal-title":"J Robotic Surg"},{"key":"2020050701580181000_ref35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12955-017-0835-1","article-title":"Prospective longitudinal outcomes of quality of life after laparoscopic radical prostatectomy compared with retropubic radical prostatectomy","volume":"16","author":"Hashine","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"2020050701580181000_ref36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10147-017-1175-1","article-title":"The 5-year outcomes of moderately hypofractionated radiotherapy (66\u00a0Gy in 22 fractions, 3 fractions per week) for localized prostate cancer: a retrospective study","volume":"23","author":"Hashimoto","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"2020050701580181000_ref37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.prnil.2017.05.004","article-title":"Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in Japanese prospective observational study (J-CaP Innovative Study-1)","volume":"6","author":"Ueno","year":"2018","journal-title":"Prostate Int"},{"key":"2020050701580181000_ref38","first-page":"169","article-title":"Quality of life worsened the most severely in patients immediately after intensity-modulated radiotherapy for prostate cancer","volume":"10","author":"Nakai","year":"2018","journal-title":"Res Rep Urol"},{"key":"2020050701580181000_ref39","article-title":"Comparison of longitudinal health-related quality-of-life outcomes between anterior and posterior surgical approaches to robot-assisted radical prostatectomy","author":"Maruyama","year":"2019","journal-title":"J Robotic Surg"},{"key":"2020050701580181000_ref40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.clgc.2017.09.009","article-title":"Recovery of serum testosterone levels and sexual function in patients treated with short-term luteinizing hormone-releasing hormone antagonist as a neoadjuvant therapy before external radiotherapy for intermediate-risk prostate cancer: preliminary prospective study","volume":"16","author":"Inoue","year":"2017","journal-title":"Clin Genitourin Cancer"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/50\/5\/519\/33180314\/hyaa027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/50\/5\/519\/33180314\/hyaa027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T06:37:26Z","timestamp":1588833446000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/50\/5\/519\/5780070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,3,4]]},"published-print":{"date-parts":[[2020,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyaa027","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,5]]},"published":{"date-parts":[[2020,3,4]]}}}